• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Monday's Intraday Session

    6/12/23 1:31:37 PM ET
    $AIH
    $AXDX
    $GRCL
    $HTGM
    Medical Specialities
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $AIH alert in real time by email

    Gainers

    • Jin Medical International (NASDAQ:ZJYL) stock rose 58.4% to $13.51 during Monday's regular session. The current volume of 4.2 million shares is 8924.5% of Jin Medical International's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $104.7 million.
    • Chinook Therapeutics (NASDAQ:KDNY) stock rose 58.31% to $37.98. Trading volume for this security as of 13:30 EST is 17.3 million, which is 2476.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.5 billion.
    • Aesthetic Medical Intl (NASDAQ:AIH) stock rose 22.91% to $1.18. Trading volume for Aesthetic Medical Intl's stock is 542.6K as of 13:30 EST. This is 13780.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.3 million.
    • Gracell Biotechnologies (NASDAQ:GRCL) stock rose 19.99% to $4.8. Trading volume for Gracell Biotechnologies's stock is 575.6K as of 13:30 EST. This is 417.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $325.0 million.
    • Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 19.63% to $0.59. Trading volume for Sonnet BioTherapeutics's stock is 2.2 million as of 13:30 EST. This is 72.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.2 million.
    • Accelerate Diagnostics (NASDAQ:AXDX) stock moved upwards by 18.91% to $0.88. As of 13:30 EST, Accelerate Diagnostics's stock is trading at a volume of 272.1K, which is 105.1% of its average full-day volume over the last 100 days. The company's market cap stands at $87.8 million.

    Losers

    • Oncorus (NASDAQ:ONCR) stock decreased by 21.7% to $0.08 during Monday's regular session. Trading volume for Oncorus's stock is 4.0 million as of 13:30 EST. This is 449.4% of its average full-day volume over the last 100 days. The company's market cap stands at $2.0 million.
    • HTG Molecular Diagnostics (NASDAQ:HTGM) stock decreased by 21.14% to $0.58. As of 13:30 EST, this security is trading at a volume of 507.9K shares, making up 227.0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 million.
    • Rockwell Medical (NASDAQ:RMTI) shares fell 16.49% to $3.8. As of 13:30 EST, Rockwell Medical's stock is trading at a volume of 904.5K, which is 369.8% of its average full-day volume over the last 100 days. The company's market cap stands at $52.2 million.
    • Mallinckrodt (AMEX:MNK) shares fell 16.04% to $1.1. As of 13:30 EST, Mallinckrodt's stock is trading at a volume of 206.5K, which is 14.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.4 million.
    • Oncology Institute (NASDAQ:TOI) stock decreased by 15.31% to $0.53. Oncology Institute's stock is trading at a volume of 1.7 million shares as of 13:30 EST. This is 266.1% of its average full-day volume over the last 100 days. The company's market cap stands at $39.5 million.
    • Miromatrix Medical (NASDAQ:MIRO) stock declined by 14.36% to $1.37. The current volume of 688.0K shares is 1252.2% of Miromatrix Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $37.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AIH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIH
    $AXDX
    $GRCL
    $HTGM

    CompanyDatePrice TargetRatingAnalyst
    The Oncology Institute Inc.
    $TOI
    11/25/2025$5.00Buy
    Needham
    The Oncology Institute Inc.
    $TOI
    7/23/2025$8.00Outperform
    Noble Capital Markets
    The Oncology Institute Inc.
    $TOI
    7/16/2025$6.00Buy
    B. Riley Securities
    The Oncology Institute Inc.
    $TOI
    5/15/2025$7.00Buy
    BTIG Research
    Rockwell Medical Inc.
    $RMTI
    11/14/2024$5.00Buy
    Rodman & Renshaw
    The Oncology Institute Inc.
    $TOI
    2/26/2024$2.50Buy
    Jefferies
    Gracell Biotechnologies Inc.
    $GRCL
    11/27/2023Outperform
    Evercore ISI
    Gracell Biotechnologies Inc.
    $GRCL
    10/19/2023$11.00Buy
    Stifel
    More analyst ratings

    $AIH
    $AXDX
    $GRCL
    $HTGM
    SEC Filings

    View All

    SEC Form 10-K filed by The Oncology Institute Inc.

    10-K - Oncology Institute, Inc. (0001799191) (Filer)

    3/12/26 4:56:06 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    3/12/26 4:05:29 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    2/23/26 4:44:16 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $AIH
    $AXDX
    $GRCL
    $HTGM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026

    CERRITOS, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2025. Recent Operational Highlights Cash flow from operations in Q4 2025 was approximately $3.2 million, due to disciplined working capital management and overall increase in gross profit marginContinued expansion of our capitated footprint, initiating 9 new capitated contracts during 2025 in CA, FL, and NV, representing approximately 260,000 additional lives under managementFurther ramped our capitation

    3/12/26 4:05:00 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative

    CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that its Board of Directors has approved an 1-for-20 share combination of all its authorized and issued ordinary shares (the "Stock Combination") pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 30, 2026 (the "EGM"). Effective as of the date of the EGM, the Company's authorized share capital is reclassified into a dual class of Class A ordinary shares

    3/11/26 7:30:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI)  a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13758646. The

    2/26/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $AIH
    $AXDX
    $GRCL
    $HTGM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Hively Brad bought $47,168 worth of shares (45,280 units at $1.04), increasing direct ownership by 7% to 712,033 units (SEC Form 4)

    4/A - Oncology Institute, Inc. (0001799191) (Issuer)

    4/28/25 7:20:14 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Large owner Irrevocable Larson Family Investment Trust bought $94,018 worth of shares (87,500 units at $1.07), increasing direct ownership by 3% to 3,557,500 units (SEC Form 4)

    4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)

    4/15/25 2:02:44 PM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Virnich Daniel bought $23,584 worth of shares (22,640 units at $1.04), increasing direct ownership by 3% to 724,363 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    3/28/25 5:50:27 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $AIH
    $AXDX
    $GRCL
    $HTGM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on The Oncology Institute with a new price target

    Needham initiated coverage of The Oncology Institute with a rating of Buy and set a new price target of $5.00

    11/25/25 8:00:05 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Noble Capital Markets initiated coverage on The Oncology Institute with a new price target

    Noble Capital Markets initiated coverage of The Oncology Institute with a rating of Outperform and set a new price target of $8.00

    7/23/25 9:21:53 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    B. Riley Securities initiated coverage on The Oncology Institute with a new price target

    B. Riley Securities initiated coverage of The Oncology Institute with a rating of Buy and set a new price target of $6.00

    7/16/25 7:58:29 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $AIH
    $AXDX
    $GRCL
    $HTGM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Stolper Mark

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    1/12/26 4:57:19 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Amendment: Chief Financial Officer Carter Robert Ross disposed of $895 worth of shares (244 units at $3.67), decreasing direct ownership by 0.10% to 235,125 units (SEC Form 4)

    4/A - Oncology Institute, Inc. (0001799191) (Issuer)

    1/6/26 4:30:02 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Carter Robert Ross sold $879 worth of shares (247 units at $3.56), decreasing direct ownership by 0.10% to 235,122 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    1/5/26 5:04:59 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $AIH
    $AXDX
    $GRCL
    $HTGM
    Leadership Updates

    Live Leadership Updates

    View All

    The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

    CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has serve

    2/23/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Announces Addition of Board Member Mark Stolper

    CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026. Mr. Stolper brings significant public markets, financial and operational leadership experience to The Oncology Institute's board. Mr. Stolper serves as Executive Vice President and Chief Financial Officer of RadNet, Inc. (NASDAQ:RDNT), a position he has held since 2004. Mr. Stolper has also been a member of the Board of Directors of various publicly traded and privately held healthcare companies, including 21st Century Oncolog

    1/5/26 8:30:00 AM ET
    $RDNT
    $TOI
    Medical Specialities
    Health Care
    Medical/Nursing Services

    The Oncology Institute Announces Resignation of Board Member Gabe Ling

    CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe Ling has resigned from the Board of Directors, effective December 1, 2025. A formal search process has been initiated to add new independent directors with complementary healthcare, clinical, and value-based care expertise. "On behalf of the Board of Directors, I want to thank Gabe for his service during an important chapter in The Oncology Institute's development," said Anne McGeorge, Chairman of the Board. "We appreciate the contributions he made throughout his time on the Board and the valua

    12/1/25 8:30:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $AIH
    $AXDX
    $GRCL
    $HTGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Accelerate Diagnostics Inc.

    SC 13D/A - Accelerate Diagnostics, Inc (0000727207) (Subject)

    12/5/24 5:13:13 PM ET
    $AXDX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Rockwell Medical Inc.

    SC 13G/A - ROCKWELL MEDICAL, INC. (0001041024) (Subject)

    11/14/24 5:17:40 PM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Accelerate Diagnostics Inc.

    SC 13G - Accelerate Diagnostics, Inc (0000727207) (Subject)

    11/14/24 3:24:23 PM ET
    $AXDX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AIH
    $AXDX
    $GRCL
    $HTGM
    Financials

    Live finance-specific insights

    View All

    The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026

    CERRITOS, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2025. Recent Operational Highlights Cash flow from operations in Q4 2025 was approximately $3.2 million, due to disciplined working capital management and overall increase in gross profit marginContinued expansion of our capitated footprint, initiating 9 new capitated contracts during 2025 in CA, FL, and NV, representing approximately 260,000 additional lives under managementFurther ramped our capitation

    3/12/26 4:05:00 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI)  a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13758646. The

    2/26/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026

    Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the fourth quarter and full-year ended December 31, 2025 on Thursday, March 26, 2026. The Company will issue a press release at 6:00am ET followed by a live webcast at 8:00am ET. WEBCAST DETAILS Date: Thursday, March 26, 2026 Time: 8:00am ET Webcast and Replay: www.RockwellMed.com/Results Speakers: Mark Strobeck, Ph.D. — President and Chief Executive Officer Jesse Neri — SVP, Chief Financial Off

    2/26/26 6:00:00 AM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care